61 related articles for article (PubMed ID: 10624422)
21. Analysis of Bcl-2 protein expression in choroidal melanomas.
Hussein MR
J Clin Pathol; 2005 May; 58(5):486-9. PubMed ID: 15858118
[TBL] [Abstract][Full Text] [Related]
22. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
23. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity in proliferation markers in colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B
Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859
[TBL] [Abstract][Full Text] [Related]
25. A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma.
Ramsden AJ; Grover R; Chana J; Tulley P; Sanders R; Wilson GD
J Plast Reconstr Aesthet Surg; 2007; 60(6):626-30. PubMed ID: 17485049
[TBL] [Abstract][Full Text] [Related]
26. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
27. The clinical significance of c-myc oncogene expression in melanomas of the scalp.
Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877
[TBL] [Abstract][Full Text] [Related]
28. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
[TBL] [Abstract][Full Text] [Related]
30. T-cell distribution and adhesion receptor expression in metastatic melanoma.
Weishaupt C; Munoz KN; Buzney E; Kupper TS; Fuhlbrigge RC
Clin Cancer Res; 2007 May; 13(9):2549-56. PubMed ID: 17473183
[TBL] [Abstract][Full Text] [Related]
31. DNA ploidy pattern in choroidal melanoma: correlation with survival. A flow cytometry study on archival material.
Toti P; Greco G; Mangiavacchi P; Bruni A; Palmeri ML; Luzi P
Br J Ophthalmol; 1998 Dec; 82(12):1433-7. PubMed ID: 9930278
[TBL] [Abstract][Full Text] [Related]
32. C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity.
Grover R; Ross DA; Richman PI; Robinson B; Wilson GD
Eur J Surg Oncol; 1996 Aug; 22(4):342-6. PubMed ID: 8783648
[TBL] [Abstract][Full Text] [Related]
33. C-myc oncogene expression in ocular melanomas.
Royds JA; Sharrard RM; Parsons MA; Lawry J; Rees R; Cottam D; Wagner B; Rennie IG
Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):366-71. PubMed ID: 1505770
[TBL] [Abstract][Full Text] [Related]
34. Deoxyribonucleic acid ploidy studies in choroidal melanomas.
Coleman K; Baak JP; Dorman A; Mullaney J; Curran B; Tiernan D; Farrell M; Fenton M; Leader M
Am J Ophthalmol; 1993 Mar; 115(3):376-83. PubMed ID: 8442500
[TBL] [Abstract][Full Text] [Related]
35. Estrogen and progesterone receptor analysis in ocular melanomas.
Foss AJ; Alexander RA; Guille MJ; Hungerford JL; McCartney AC; Lightman S
Ophthalmology; 1995 Mar; 102(3):431-5. PubMed ID: 7891981
[TBL] [Abstract][Full Text] [Related]
36. Antigenic and cellular heterogeneity of primary uveal malignant melanomas.
Donoso LA; Shields JA; Augsburger JJ; Whitman J; Arbizo V
Arch Ophthalmol; 1986 Jan; 104(1):106-10. PubMed ID: 3942530
[TBL] [Abstract][Full Text] [Related]
37. Sequential DNA flow cytometry in metastatic malignant melanoma.
Bartkowiak D; Otto F; Schumann J; Lippold A; Drepper H
Oncology; 1991; 48(2):154-7. PubMed ID: 1997939
[TBL] [Abstract][Full Text] [Related]
38. The clinical status of immunoscintigraphy with monoclonal antibodies in ocular melanoma.
Schaling DF; Jager MJ; van Kroonenburg MJ; Oosterhuis JA; Pauwels EK
Int J Biol Markers; 1991; 6(1):25-30. PubMed ID: 1856514
[TBL] [Abstract][Full Text] [Related]
39. Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former.
Chi HI; Uyeda Y; Umebayashi Y; Otsuka F
Arch Dermatol Res; 1993; 285(7):410-4. PubMed ID: 8304780
[TBL] [Abstract][Full Text] [Related]
40. Primary solitary intracranial melanoma: case report and review of the literature.
Rodriguez y Baena R; Gaetani P; Danova M; Bosi F; Zappoli F
Surg Neurol; 1992 Jul; 38(1):26-37. PubMed ID: 1615371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
